Ethicon Endo-Surgery acquires SurgRx
This acquisition brings together two complementary energy technologies in the evolving global energy segment. The combined portfolio of Enseal products and the Ethicon Endo-Surgery Harmonic line of ultrasonic
Swedish Orphan Biovitrum (Sobi) has received a complete response letter from the US Food and Drug Administration (FDA) regarding its biologics licence application for nanoencapsulated sirolimus plus pegadricase (NASP), an investigational therapy intended for adults with uncontrolled gout.